Thermo Fisher Scientific Inc.
TMO · NYSE
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,621 | $1,615 | $1,515 | $1,824 |
| Dep. & Amort. | $662 | $685 | $706 | $740 |
| Deferred Tax | -$127 | -$322 | -$279 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $2,151 | -$726 | -$1,425 | $594 |
| Other Non-Cash | -$2,068 | $147 | $206 | $132 |
| Operating Cash Flow | $2,239 | $1,399 | $723 | $3,290 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$404 | -$294 | -$362 | -$480 |
| Net Acquisitions | -$4,037 | $0 | $0 | $0 |
| Inv. Purchases | -$40 | -$47 | -$264 | $0 |
| Inv. Sales/Matur. | $254 | $0 | $0 | $0 |
| Other Inv. Act. | $104 | $53 | $99 | $500 |
| Investing Cash Flow | -$4,123 | -$288 | -$527 | $20 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,000 | -$787 | $2,002 | -$2,500 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $2,000 | $0 | -$2,000 | -$1,000 |
| Dividends Paid | -$163 | -$162 | -$149 | -$149 |
| Other Fin. Act. | -$469 | -$42 | $45 | -$17 |
| Financing Cash Flow | -$632 | -$991 | -$102 | -$3,666 |
| Forex Effect | -$75 | $311 | $37 | -$273 |
| Net Chg. in Cash | -$2,592 | $431 | $131 | -$630 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,603 | $4,172 | $4,040 | $4,670 |
| End Cash | $2,011 | $4,603 | $4,172 | $4,040 |
| Free Cash Flow | $1,835 | $1,105 | $361 | $2,810 |